Maven Securities’s Day One Biopharmaceuticals DAWN Stock Holding History

Maven Securities’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-103,900	Closed	-$2.23M	–	360
2026 Q1	$2.23M	Buy	+103,900	New	+$1.46M	0.04%	255
2023 Q2	–	Sell	-100,000	Closed	-$1.34M	–	902
2023 Q1	$1.34M	Buy	+100,000	New	+$1.95M	0.03%	386
2022 Q3	–	Sell	-80,000	Closed	-$1.43M	–	1116
2022 Q2	$1.43M	Buy	+80,000	New	+$826K	0.04%	283
2021 Q3	–	Sell	-9,000	Closed	-$210K	–	1091
2021 Q2	$210K	Buy	+9,000	New	+$188K	0.01%	930

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Maven Securities's DAWN Position: Q2 2026 in Review

Maven Securities sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 103,900 shares — an estimated $2.23M sold.

Maven Securities first reported a position in DAWN in Q2 2021 and held it in 4 quarters. The position peaked at $2.23M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Maven Securities reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Maven Securities sold 103,900 Day One Biopharmaceuticals shares in Q2 2026, an estimated $2.23M.
Maven Securities first reported a position in Day One Biopharmaceuticals in Q2 2021 and held it in 4 quarters.
Maven Securities's Day One Biopharmaceuticals position peaked at $2.23M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Maven Securities's 13F filing for Q2 2026, filed 14 Aug 2026.